Search research articles
Contact Us
Filters
Showing results (41-50 of 94) with videos related to
Page
of 10
Sort By:
The Journal of Vascular Access
|
April 9, 2016
Retrospective data about the catheter-related complications and management in massive bus burn casualties
Hongfei Jiang, Hang Hu, Haitao Ren, et al.
Nanoscale
|
December 19, 2022
Tetrazine bioorthogonal chemistry makes nanotechnology a powerful toolbox for biological applications
Renshuai Zhang, Jiake Gao, Gaoxiang Zhao, et al.
Frontiers in Pharmacology
|
April 3, 2025
The potential of ARL4C and its-mediated genes in atherosclerosis and agent development
Dan Liu, Jie Wang, Shuangshuang Zhang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
December 12, 2023
3-aryl-4-(3,4,5-trimethoxyphenyl)pyridines inhibit tubulin polymerisation and act as anticancer agents
Chao Wang, Yujing Zhang, Shanbo Yang, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao
|
July 30, 2021
Fructose and fructose kinase in cancer and other pathologies
Hongfei Jiang, Qian Lin, Leina Ma, et al.
European Journal of Medicinal Chemistry
|
January 22, 2022
Niemann-Pick C1-Like 1 inhibitors for reducing cholesterol absorption
Renshuai Zhang, Wenjing Liu, Jun Zeng, et al.
European Journal of Medicinal Chemistry
|
December 10, 2024
Hypoxia-selective prodrug restrains tumor cells through triggering mitophagy and inducing apoptosis
Fangjie Wang, Lairong Song, Qianqian Xu, et al.
European Journal of Medicinal Chemistry
|
October 3, 2024
Stimuli-responsive prodrugs with self-immolative linker for improved cancer therapy
Wenting Xu, Ang Jia, Zhixian Lei, et al.
European Journal of Medicinal Chemistry
|
September 24, 2024
Discovery and biological evaluation of 6-aryl-4-(3,4,5-trimethoxyphenyl)quinoline derivatives with promising antitumor activities as novel colchicine-binding site inhibitors
Qianqian Xu, Yuxuan Tu, Yujing Zhang, et al.
Pharmacological Research
|
July 17, 2023
Novel application potential of cinaciguat in the treatment of mixed hyperlipidemia through targeting PTL/NPC1L1 and alleviating intestinal microbiota dysbiosis and metabolic disorders
Ang Jia, Hongfei Jiang, Wenjing Liu, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 94) with videos related to
Sort By:
Page
of 10
The Journal of Vascular Access
|
April 9, 2016
Retrospective data about the catheter-related complications and management in massive bus burn casualties
Hongfei Jiang, Hang Hu, Haitao Ren, et al.
Nanoscale
|
December 19, 2022
Tetrazine bioorthogonal chemistry makes nanotechnology a powerful toolbox for biological applications
Renshuai Zhang, Jiake Gao, Gaoxiang Zhao, et al.
Frontiers in Pharmacology
|
April 3, 2025
The potential of ARL4C and its-mediated genes in atherosclerosis and agent development
Dan Liu, Jie Wang, Shuangshuang Zhang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
December 12, 2023
3-aryl-4-(3,4,5-trimethoxyphenyl)pyridines inhibit tubulin polymerisation and act as anticancer agents
Chao Wang, Yujing Zhang, Shanbo Yang, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao
|
July 30, 2021
Fructose and fructose kinase in cancer and other pathologies
Hongfei Jiang, Qian Lin, Leina Ma, et al.
European Journal of Medicinal Chemistry
|
January 22, 2022
Niemann-Pick C1-Like 1 inhibitors for reducing cholesterol absorption
Renshuai Zhang, Wenjing Liu, Jun Zeng, et al.
European Journal of Medicinal Chemistry
|
December 10, 2024
Hypoxia-selective prodrug restrains tumor cells through triggering mitophagy and inducing apoptosis
Fangjie Wang, Lairong Song, Qianqian Xu, et al.
European Journal of Medicinal Chemistry
|
October 3, 2024
Stimuli-responsive prodrugs with self-immolative linker for improved cancer therapy
Wenting Xu, Ang Jia, Zhixian Lei, et al.
European Journal of Medicinal Chemistry
|
September 24, 2024
Discovery and biological evaluation of 6-aryl-4-(3,4,5-trimethoxyphenyl)quinoline derivatives with promising antitumor activities as novel colchicine-binding site inhibitors
Qianqian Xu, Yuxuan Tu, Yujing Zhang, et al.
Pharmacological Research
|
July 17, 2023
Novel application potential of cinaciguat in the treatment of mixed hyperlipidemia through targeting PTL/NPC1L1 and alleviating intestinal microbiota dysbiosis and metabolic disorders
Ang Jia, Hongfei Jiang, Wenjing Liu, et al.
Page
of 10